Prospective validation of Fibrotest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kim, Beom Kyung ^a   Kim, Seung Up ^a   Kim, Hyon Suk ^a   Park, Jun Yong ^a   Ahn, Sang Hoon ^a   Chon, Chae Yoon ^a   Cho, In Rae ^a   Joh, Dong Hoo ^a   Park, Young Nyun ^a   Han, Kwang Hyub ^a   Kim, Do Young ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; ASIAN; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM EXAMINATION; FEMALE; FIBROTEST; HEPATITIS B; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VALIDITY; BIOPSY; BLOOD; COMPARATIVE STUDY; ELASTICITY; ELASTOGRAPHY; HEPATITIS B VIRUS; LIVER; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; VALIDATION STUDY; VIROLOGY;

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN;

ADULT; ALPHA-MACROGLOBULINS; APOLIPOPROTEIN A-I; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BILIRUBIN; BIOLOGICAL MARKERS; BIOPSY; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HAPTOGLOBINS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84859957692     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035825     Document Type: Article

References (42)

1. Lok AS, McMahon BJ, (2007) Chronic hepatitis B. Hepatology 45: 507-539.
2. Degertekin B, Lok AS, (2009) Indications for therapy in hepatitis B. Hepatology 49: S129-137.
3. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, et al. (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. New England Journal of Medicine 351: 1521-1531.
4. de Franchis R, (2008) Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 49: 520-527.
5. Spinzi G, Terruzzi V, Minoli G, (2001) Liver biopsy. New England Journal of Medicine 344: 2030.
6. Poynard T, Halfon P, Castera L, Charlotte F, Le Bail B, et al. (2007) Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Alimentary Pharmacology and Therapeutics 25: 733-739.
7. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526.
8. Sheth SG, Flamm SL, Gordon FD, Chopra S, (1998) AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. The American journal of gastroenterology 93: 44-48.
9. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, et al. (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36: 986-992.
10. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, et al. (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357: 1069-1075.
11. Lim SG, Oo AM, Mak B, Chua W, Chan E, et al. (2006) Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver international 26: 666-672.
12. Han KH, Yoon KT, (2008) New diagnostic method for liver fibrosis and cirrhosis. Intervirology 51 (Suppl 1): 11-16.
13. Lackner C, Struber G, Liegl B, Leibl S, Ofner P, et al. (2005) Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 41: 1376-1382.
14. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128: 343-350.
15. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, et al. (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134: 960-974.
16. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, et al. (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41: 48-54.
17. Kim SU, Han KH, Ahn SH, (2010) Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol 16: 5173-5180.
18. Shaheen AA, Wan AF, Myers RP, (2007) FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 102: 2589-2600.
19. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, et al. (2007) Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 7: 40.
20. Halfon P, Munteanu M, Poynard T, (2008) FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol 32: 22-39.
21. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, et al. (2003) Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 39: 222-230.
22. Sebastiani G, Vario A, Guido M, Alberti A, (2007) Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 13: 525-531.
23. Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut F, et al. (2005) Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gastroenterol 100: 1970-1980.
24. Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, et al. (2011) Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol 46: 962-972.
25. Raftopoulos SC, George J, Bourliere M, Rossi E, de Boer WB, et al. (2011) Comparison of noninvasive models of fibrosis in chronic hepatitis B. Hepatol Int.
26. Kim SU, Ahn SH, Park JY, Kang W, Kim DY, et al. (2008) Liver Stiffness Measurement in Combination With Noninvasive Markers for the Improved Diagnosis of B-viral Liver Cirrhosis. J Clin Gastroenterol 43: 267-271.
27. Castera L, Forns X, Alberti A, (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48: 835-847.
28. Batts KP, Ludwig J, (1995) Chronic hepatitis. An update on terminology and reporting. American journal of surgical pathology 19: 1409-1417.
29. Hanley JA, McNeil BJ, (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843.
30. Fluss R, Faraggi D, Reiser B, (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47: 458-472.
31. Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128: 343-350.
32. Kim BK, Kim do Y, Park JY, Ahn SH, Chon CY, et al. (2010) Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver int 30: 546-553.
33. Chang PE, Lui HF, Chau YP, Lim KH, Yap WM, et al. (2008) Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. Alimentary pharmacology & therapeutics 28: 51-61.
34. Kim BK, Han KH, Park JY, Ahn SH, Chon CY, et al. (2010) A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients. Liver int 30: 1073-1081.
35. Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, et al. (2011) Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 53: 885-894.
36. Kim do Y, Kim SU, Ahn SH, Park JY, Lee JM, et al. (2009) Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 54: 1758-1763.
37. Fontaine H, Petitprez K, Roudot-Thoraval F, Trinchet JC, (2007) Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol 31: 504-509.
38. Afdhal NH, (2003) Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 37: 972-974.
39. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, et al. (2004) Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 50: 1344-1355.
40. Bedossa P, Dargere D, Paradis V, (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38: 1449-1457.
41. Kim SU, Seo YS, Cheong JY, Kim MY, Kim JK, et al. (2010) Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 32: 498-505.
42. Fung J, Lai CL, Cheng C, Wu R, Wong DK, et al. (2011) Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol 106: 492-496.